Hematology/Oncology

Top Story

Allogeneic HSCT survival outcomes show ‘striking improvement’

Allogeneic HSCT survival outcomes show ‘striking improvement’
January 20, 2020
In the Journals

Physicians should counsel patients on safe use of cannabis edibles

January 20, 2020
Physicians need to better promote open discussions with patients who express interest in cannabis on their use of edibles, enable counseling on safe consumption, and…
In the Journals

Oral anticoagulants may be harmful in patients with AF on dialysis

January 20, 2020
Among patients with atrial fibrillation on long-term dialysis, oral anticoagulants were not associated with decreased risk for thromboembolism and some of them elevated…

Pralsetinib effective, safe for RET fusion-positive NSCLC

January 20, 2020
The investigational therapy pralsetinib appeared effective and safe for patients with RET fusion-positive non-small cell lung cancer, according to topline data released…
Trend Watch

Astellas partners with Adaptimmune to develop off-the-shelf CAR-T and T-cell therapies

January 20, 2020
Astellas Pharma announced a research and commercialization deal with Adaptimmune for the codevelopment of new stem cell-derived allogeneic chimeric antigen receptor and…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next